Wednesday

27th Jan 2021

Coronavirus

Hungary must keep Russian vaccine within borders, says EU

Hungary can purchase and distribute the Russian-made vaccine against Covid-19 - but only if it invokes emergency procedures and keeps it within its own borders, the EU warned on Monday (30 November).

"The vaccine cannot be circulated elsewhere in the European Union other than Hungary," chief European Commission spokesperson, Eric Mamer, told reporters.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

The government in Budapest may end up rolling out the Russian-made vaccine Sputnik V, named after the Soviet-era space programme, without first getting market authorisation from the Amsterdam-based European Medicines Agency (EMA).

The agency is tasked to ensure vaccines are safe and effective before they are distributed for wider use in the European Union.

Any vaccine based on biotechnologies must also first secure approval from the agency prior to roll out.

However, a member state may skip the agency altogether - but only if it invokes specific national emergency procedures.

Such emergency procedures also have to be limited in duration.

"It is a decision which will be taken by the Hungarian authorities and they are the ones who will assume full responsibility for follow up," said Stefan de Keersmaecker, the commission's spokesperson on health.

He noted that no data or information on the Russian vaccine has so far been shared.

Nor has the EMA received a request for Sputnik V market-authorisation.

But it is holding discussions with its developer, a state-run institute.

Russia became the first country to approve an anti Covid-19 vaccine, in early August. But critics say the approval was rushed, given it had not completed standard testing phases.

The vaccine initially claimed to be 92 percent effective. The figure increased to 95 percent following announcement results of similar vaccines by Pfizer-Biotech and Moderna.

Sputnik V was licensed based on trials involving 76 people, which then increased to 18,000, leading to the 95 percent figure.

Hungary is the first EU state to secure the Russian vaccine, amid plans to launch clinical trials this month.

Larger shipments to Hungary would then be sent in the second half of January, if the virus is deemed effective. Budapest is also mulling purchases from Israel and China.

Investigation

EU taxpayers in the dark on US corona-drug deal

The EU recently signed a huge contract for a US anti-corona drug which, the WHO says, might not work, but there's little transparency on how the deal was made.

EU seeks new deal for '90% effective' Covid-19 vaccine

After an experimental Covid-19 vaccine developed by the American giant Pfizer and its German partner BioNTech was found to be more than 90 percent effective, the EU announced that it will sign a contract for up to 300 million doses.

EU defends its slower vaccine authorisation

After the UK approved the use of the Covid-19 vaccine developed by Pfizer/BioNtech, the pressure is mounting on the EU. But how are these vaccines approved in the bloc - and what is the legal liability?

EU adds new 'dark red' zone to travel-restrictions map

The European Commission has proposed additional measures to limit non-essential travel within and to the European Union - amid fears over more transmissible mutations triggering a new surge in cases across the bloc.

EU seeks more health powers after dubious Covid-19 response

After the lack of coordination evidenced during the first months of the Covid-19 pandemic, the European Commission put forward a set of proposals to strengthen the preparedness of members states in cross-border health threats.

Column

BioNTech: Stop talking about their 'migration background'

I understand that the German-Turkish community - often subjected to condescension in Germany - celebrated the story. Uğur Şahin and Özlem Türecki represent scientific excellence and business success at the highest level.

Stakeholders' Highlights

  1. UNESDAEU Code of Conduct can showcase PPPs delivering healthier more sustainable society
  2. CESIKlaus Heeger and Romain Wolff re-elected Secretary General and President of independent trade unions in Europe (CESI)
  3. Nordic Council of MinistersWomen benefit in the digitalised labour market
  4. Nordic Council of MinistersReport: The prevalence of men who use internet forums characterised by misogyny
  5. Nordic Council of MinistersJoin the Nordic climate debate on 17 November!
  6. UNESDAMaking healthier diets the easy choice

Latest News

  1. Giuseppe Conte: scapegoat or Italy's most cunning politician?
  2. Borrell to meet Lavrov, while Navalny behind bars
  3. Too few central and eastern Europeans at top of EU
  4. Rift widens on 'returns' deadline in EU migration pact
  5. EU adds new 'dark red' zone to travel-restrictions map
  6. Migrants in Bosnia: a disaster foretold on EU doorstep
  7. Navalny protests sharpen EU sanctions talks
  8. Why Russia politics threaten European security

Join EUobserver

Support quality EU news

Join us